Floatz logo

Oxygen

Obstructive Sleep Apnea Syndrome

University of California, San DiegoSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Obstructive Sleep Apnea Syndrome cohort.

Asset / SponsorPhaseRating
Adalimumab
Innovaderm Research Inc.
Phase 4BB
MELATONIN
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase 4BB
Liraglutide
St Vincent's University Hospital, Ireland
Phase 3BB
Mazdutide
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3B
nnc0487-0111
Novo Nordisk A/S
Phase 3B

View all 16 →

Same molecule, other indications

Oxygen is also rated in:

Localised Prostate CancerDormant
BB
Indicative ·
66 / 100
View asset →
benign prostatic hyperplasiaDormant
BB
Indicative ·
66 / 100
View asset →
anxiety disorderDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →